Skip to main content
Top
Published in: BMC Infectious Diseases 1/2005

Open Access 01-12-2005 | Research article

Identification of moaA3 gene in patient isolates of Mycobacterium tuberculosis in Kerala, which is absent in M. tuberculosisH37Rv and H37Ra

Authors: Suma Sarojini, Smitha Soman, Indulakshmi Radhakrishnan, Sathish Mundayoor

Published in: BMC Infectious Diseases | Issue 1/2005

Login to get access

Abstract

Background

Tuberculosis is endemic to developing countries like India. Though the whole genome sequences of the type strain M. tuberculosis H37Rv and the clinical strain M. tuberculosis CDC1551 are available, the clinical isolates from India have not been studied extensively at the genome level. This study was carried out in order to have a better understanding of isolates from Kerala, a state in southern India.

Results

A PCR based strategy was followed making use of the deletion region primers to understand the genome level differences between the type strain H37Rv and the clinical isolates of M. tuberculosis from Kerala. PCR analysis of patient isolates using RD1 region primers revealed the amplification of a 386 bp region, in addition to the expected 652 bp amplicon. Southern hybridization of genomic DNA with the 386 bp amplicon confirmed the presence of this new region in a majority of the patient isolates from Kerala. Sequence comparison of this amplicon showed close homology with the moaA3 gene of M. bovis. In M. bovis this gene is present in the RvD5 region, an IS6110 mediated deletion that is absent in M. tuberculosis H37Rv.

Conclusion

This study demonstrates the presence of moaA3 gene, that is absent in M. tuberculosis H37Rv and H37Ra, in a large number of local isolates. Whether the moaA3 gene provides any specific advantage to the field isolates of the pathogen is unclear. Field strains from Kerala have fewer IS6110 sequences and therefore are likely to have fewer IS6110 dependent rearrangements. But as deletions and insertions account for much of the genomic diversity of M. tuberculosis, the mechanisms of formation of sequence polymorphisms in the local isolates should be further examined. These results suggest that studies should focus on strains from endemic areas to understand the complexities of this pathogen.
Appendix
Available only for authorised users
Literature
1.
go back to reference TB a global emergency-WHO report on the TB epidemic. 1994, Geneva , World Health Organization TB a global emergency-WHO report on the TB epidemic. 1994, Geneva , World Health Organization
2.
go back to reference Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, J S, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998, 393 (6685): 537-544. 10.1038/31159.CrossRefPubMed Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, J S, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998, 393 (6685): 537-544. 10.1038/31159.CrossRefPubMed
3.
go back to reference Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WRJ, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002, 184 (19): 5479-5490. 10.1128/JB.184.19.5479-5490.2002.CrossRefPubMedPubMedCentral Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WRJ, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002, 184 (19): 5479-5490. 10.1128/JB.184.19.5479-5490.2002.CrossRefPubMedPubMedCentral
4.
go back to reference Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, Duthoy S, Grondin S, Lacroix C, Monsempe C, Simon S, Harris B, Atkin R, Doggett J, Mayes R, Keating L, Wheeler PR, Parkhill J, Barrell BG, Cole ST, Gordon SV, Hewinson RG: The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A. 2003, 100 (13): 7877-7882. 10.1073/pnas.1130426100.CrossRefPubMedPubMedCentral Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, Duthoy S, Grondin S, Lacroix C, Monsempe C, Simon S, Harris B, Atkin R, Doggett J, Mayes R, Keating L, Wheeler PR, Parkhill J, Barrell BG, Cole ST, Gordon SV, Hewinson RG: The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A. 2003, 100 (13): 7877-7882. 10.1073/pnas.1130426100.CrossRefPubMedPubMedCentral
5.
go back to reference Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK: Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996, 178 (5): 1274-1282.PubMedPubMedCentral Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK: Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996, 178 (5): 1274-1282.PubMedPubMedCentral
6.
go back to reference Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999, 284 (5419): 1520-1523. 10.1126/science.284.5419.1520.CrossRefPubMed Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999, 284 (5419): 1520-1523. 10.1126/science.284.5419.1520.CrossRefPubMed
7.
go back to reference Brosch R, Philipp WJ, Stavropoulos E, Colston MJ, Cole ST, Gordon SV: Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun. 1999, 67 (11): 5768-5774.PubMedPubMedCentral Brosch R, Philipp WJ, Stavropoulos E, Colston MJ, Cole ST, Gordon SV: Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun. 1999, 67 (11): 5768-5774.PubMedPubMedCentral
8.
go back to reference Radhakrishnan I, K MY, Kumar RA, Mundayoor S: Implications of low frequency of IS6110 in fingerprinting field isolates of Mycobacterium tuberculosis from Kerala, India. J Clin Microbiol. 2001, 39 (4): 1683-10.1128/JCM.39.4.1683.2001.CrossRefPubMedPubMedCentral Radhakrishnan I, K MY, Kumar RA, Mundayoor S: Implications of low frequency of IS6110 in fingerprinting field isolates of Mycobacterium tuberculosis from Kerala, India. J Clin Microbiol. 2001, 39 (4): 1683-10.1128/JCM.39.4.1683.2001.CrossRefPubMedPubMedCentral
9.
go back to reference Siddiqi N, Shamim M, Amin A, Chauhan DS, Das R, Srivastava K, Singh D, Sharma VD, Katoch VM, Sharma SK, Hanief M, Hasnain SE: Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism. Infect Genet Evol. 2001, 1 (2): 109-116. 10.1016/S1567-1348(01)00014-4.CrossRefPubMed Siddiqi N, Shamim M, Amin A, Chauhan DS, Das R, Srivastava K, Singh D, Sharma VD, Katoch VM, Sharma SK, Hanief M, Hasnain SE: Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism. Infect Genet Evol. 2001, 1 (2): 109-116. 10.1016/S1567-1348(01)00014-4.CrossRefPubMed
10.
go back to reference Mathema B, Bifani PJ, Driscoll J, Steinlein L, Kurepina N, Moghazeh SL, Shashkina E, Marras SA, Campbell S, Mangura B, Shilkret K, Crawford JT, Frothingham R, Kreiswirth BN: Identification and evolution of an IS6110 low-copy-number Mycobacterium tuberculosis cluster. J Infect Dis. 2002, 185 (5): 641-649. 10.1086/339345.CrossRefPubMed Mathema B, Bifani PJ, Driscoll J, Steinlein L, Kurepina N, Moghazeh SL, Shashkina E, Marras SA, Campbell S, Mangura B, Shilkret K, Crawford JT, Frothingham R, Kreiswirth BN: Identification and evolution of an IS6110 low-copy-number Mycobacterium tuberculosis cluster. J Infect Dis. 2002, 185 (5): 641-649. 10.1086/339345.CrossRefPubMed
11.
go back to reference Warren RM, Victor TC, Streicher EM, Richardson M, van der Spuy GD, Johnson R, Chihota VN, Locht C, Supply P, van Helden PD: Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol. 2004, 42 (12): 5774-5782. 10.1128/JCM.42.12.5774-5782.2004.CrossRefPubMedPubMedCentral Warren RM, Victor TC, Streicher EM, Richardson M, van der Spuy GD, Johnson R, Chihota VN, Locht C, Supply P, van Helden PD: Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol. 2004, 42 (12): 5774-5782. 10.1128/JCM.42.12.5774-5782.2004.CrossRefPubMedPubMedCentral
12.
go back to reference Das SD, Narayanan S, Hari L, Hoti SL, Thangathurai RK, Charles N, Jaggarajamma K, Narayanan PR: Differentiation of highly prevalent IS6110 single-copy strains of Mycobacterium tuberculosis from a rural community in South India with an ongoing DOTS programme. Infect Genet Evol. 2005, 5 (1): 67-77. 10.1016/j.meegid.2004.06.007.PubMed Das SD, Narayanan S, Hari L, Hoti SL, Thangathurai RK, Charles N, Jaggarajamma K, Narayanan PR: Differentiation of highly prevalent IS6110 single-copy strains of Mycobacterium tuberculosis from a rural community in South India with an ongoing DOTS programme. Infect Genet Evol. 2005, 5 (1): 67-77. 10.1016/j.meegid.2004.06.007.PubMed
13.
go back to reference Pym AS, Brodin P, Brosch R, Huerre M, Cole ST: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002, 46 (3): 709-717. 10.1046/j.1365-2958.2002.03237.x.CrossRefPubMed Pym AS, Brodin P, Brosch R, Huerre M, Cole ST: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002, 46 (3): 709-717. 10.1046/j.1365-2958.2002.03237.x.CrossRefPubMed
14.
go back to reference Leimkuhler S, Rajagopalan KV: In vitro incorporation of nascent molybdenum cofactor into human sulfite oxidase. J Biol Chem. 2001, 276 (3): 1837-1844. 10.1074/jbc.M007304200.CrossRefPubMed Leimkuhler S, Rajagopalan KV: In vitro incorporation of nascent molybdenum cofactor into human sulfite oxidase. J Biol Chem. 2001, 276 (3): 1837-1844. 10.1074/jbc.M007304200.CrossRefPubMed
15.
go back to reference Janion C: A new look at adaptive mutations in bacteria. Acta Biochim Pol. 2000, 47 (2): 451-457.PubMed Janion C: A new look at adaptive mutations in bacteria. Acta Biochim Pol. 2000, 47 (2): 451-457.PubMed
16.
go back to reference Dubnau E, Chan J, Mohan VP, Smith I: responses of mycobacterium tuberculosis to growth in the mouse lung. Infect Immun. 2005, 73 (6): 3754-3757. 10.1128/IAI.73.6.3754-3757.2005.CrossRefPubMedPubMedCentral Dubnau E, Chan J, Mohan VP, Smith I: responses of mycobacterium tuberculosis to growth in the mouse lung. Infect Immun. 2005, 73 (6): 3754-3757. 10.1128/IAI.73.6.3754-3757.2005.CrossRefPubMedPubMedCentral
17.
go back to reference van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD: Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991, 29 (11): 2578-2586.PubMedPubMedCentral van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD: Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991, 29 (11): 2578-2586.PubMedPubMedCentral
18.
go back to reference Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM: Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination[]. Proc Natl Acad Sci U S A. 1997, 94 (18): 9869-9874. 10.1073/pnas.94.18.9869.CrossRefPubMedPubMedCentral Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM: Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination[]. Proc Natl Acad Sci U S A. 1997, 94 (18): 9869-9874. 10.1073/pnas.94.18.9869.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of moaA3 gene in patient isolates of Mycobacterium tuberculosis in Kerala, which is absent in M. tuberculosisH37Rv and H37Ra
Authors
Suma Sarojini
Smitha Soman
Indulakshmi Radhakrishnan
Sathish Mundayoor
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2005
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-5-81

Other articles of this Issue 1/2005

BMC Infectious Diseases 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine